Abstract
The structure of the complex of the antibacterial drug trimethoprim with its target, the enzyme dihydrofolate reductase (DHFR) of Lactobacillus casei, was studied using multidimensional NMR spectroscopy. Aseries of 33 high-resolution structures of this complex in solution was calculated using the measured experimental parameters of the nuclear Overhauser effect, spin-spin coupling constants, and residual dipolar coupling constants. The key interactions leading to stable binding of the drug with the enzyme were determined. The resulting structural data were compared with structures of the ternary complex of trimethoprim and the coenzyme NADPH with bacterial (L. casei) and human DHFR that were calculated previously. The most probable reasons for cooperative interaction of trimethoprim and NADPH that determine the highly selective binding of the drug to the bacterial enzyme, in particular, the protein conformation change on going from the binary to the ternary complex of DHFR, were discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. Hillisch and R. Hilgenfield, Modern Methods of Drug Discovery, Birkhauser Verlag, Basel, Boston, Berlin (2002), pp. 157–182.
M. D. Mashkovskii, Vol. 2, Drugs [in Russian], Novaya Volna, Moscow (2000), pp. 282–283.
R. L. Blakley, Chemistry and Biochemistry of Folates, Vol. 1, Wiley, New York (1984).
G. H. Hitchings, Angew. Chem. Int. Ed. Engl., 28(7), 879–885 (1989).
D. P. Baccanari, S. Daluge, and R. W. King, Biochemistry, 21(20), 5068–5075 (1982).
C.-J. Tasi, R. Norel, H. J. Wolfson, et al., “Protein-ligand interactions: Energetic contributions and shape complementarity,” in: Elcyclopedia of Life Science, Vol. 15, Nature Publishing Group, London, New York & Tokyo (2002), pp. 505–512.
D. A. Matthews, J. T. Bolin, J. M. Burridge, et al., J. Biol. Chem., 260(1), 381–391 (1985).
C. R. Groom, J. Thillet, A. C. North, et al., J. Biol. Chem., 266(30), 19890–19893 (1991).
V. I. Polshakov, E. G. Smirnov, B. Birdsall, et al., J. Biomol. NMR, 24(1), 67–70 (2002).
N. V. Kovalevskaya, Y. D. Smurnyy, V. I. Polshakov, et al., J. Biomol. NMR, 33(1), 69–72 (2005).
A. R. Gargaro, A. Soteriou, T. A. Frenkiel, et al., J. Mol. Biol., 277(1), 119–134 (1998).
F. Delaglio, S. Grzesiek, G. W. Vuister, et al., J. Biomol. NMR, 6(3), 277–293 (1995).
M. D. Carr, B. Birdsall, T. A. Frenkiel, et al., Biochemistry, 30(25), 6330–6341 (1991).
V. I. Polshakov, B. Birdsall, and J. Feeney, J. Mol. Biol., 356(4), 886–903 (2006).
V. I. Polshakov, T. A. Frenkiel, B. Birdsall, et al., J. Magn. Reson. Ser. B, 108(1), 31–43 (1995).
A. T. Brunger, P. D. Adams, G. M. Clore, et al., Acta Crystallogr. Ser. D, 54(Pt 5), 905–921 (1998).
C. D. Schwieters, J. J. Kuszewski, N. Tjandra, et al., J. Magn. Reson., 160(1), 65–73 (2003).
G. C. K. Roberts, J. Feeney, A. S. V. Burgen, et al., FEBS Lett., 131(1), 85–88 (1981).
C. Bystroff and J. Kraut, Biochemistry, 30(8), 2227–2239 (1991).
V. I. Polshakov, Izv. Ross. Akad Nauk, Ser. Khim., No. 10, 1652–1669 (2002).
V. I. Polshakov, B. Birdsall, and J. Feeney, Biochemistry, 38(48), 15962–15969 (1999).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 41, No. 7, pp. 8–11, July, 2007.
Rights and permissions
About this article
Cite this article
Kovalevskaya, N.V., Smurnyi, E.D., Birdsall, B. et al. Structural factors determining the binding selectivity of the antibacterial drug trimethoprim to dihydrofolate reductase. Pharm Chem J 41, 350–353 (2007). https://doi.org/10.1007/s11094-007-0079-1
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-007-0079-1